Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Psychiatric Solutions

Explore full profile

Inpatient and outpatient behavioral healthcare services provider

Franklin, United StatesFounded 1988Health
Valuation $2.5–5B Last recorded · 2010
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Psychiatric Solutions and the history behind them.

About Psychiatric Solutions

In 1997, two former Hospital Corporation of America executives, Joey Jacobs and Bryce DeHaven, founded Psychiatric Solutions, Inc. (PSI). Initially, the company managed various outpatient psychiatric services. However, seeing a fragmented market, they pivoted in 1999 to a roll-up strategy: acquiring and operating freestanding psychiatric inpatient hospitals. This new focus on owning inpatient facilities became the core of their business. The company went public via a merger with PMR Corporation in 2002, listing on the NASDAQ. This event provided the capital to accelerate its acquisition-heavy growth model. PSI grew rapidly, owning or leasing 94 facilities by 2010. The playbook was to acquire hospitals and apply their operating efficiencies to increase profitability. This chapter culminated in a major liquidity event in 2010 when Universal Health Services (UHS) acquired Psychiatric Solutions for approximately $3.1 billion, including the assumption of debt. The deal made UHS the largest operator of inpatient psychiatric care in the United States.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
1988
Headquarters
Franklin, United States
Employees
116
Open positions
None listed
Dealroom signal
36.8/100
Industry
Health
Sector
Health
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Nov 2010 $3.1B $3.1B Universal Health Services —
SERIES A✓Equity / VC Jan 2003 $25M $100M Oak Investment · Salix Ventures · BBH Capital Partners —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Psychiatric Solutions website traffic

Latest recorded traffic for Psychiatric Solutions is 0 monthly website visits. Psychiatric Solutions's team grew 31.8% over the past year.

Latest monthly visits0 1-year team growth+31.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
SecondWave SystemsDeveloping a novel, ultrasound-based wearable neuromodulation platform Minneapolis, United States Operational 19 $17M $28M
FunPepFunPep is an Industry-university collaboration bioventure company Ibaraki, Japan Operational
Arterial Health InternationalProvides clinical diagnostic tests for a comprehensive evaluation of cardiovascular disease risk factors Atlanta, United States Operational
LysoclearPremium laboratory research services for biotechnology and pharmaceutical companies, specializing in ocular toxicology and structural biology Lafayette, United States Operational
TAGCyx BiotechnologiesCreating candidate compounds for high-performance nucleic acid drugs with high affinity and specificity for target molecules using our proprietary nucleic acid basic technology Tokyo, Japan Acquired
Amygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction Palo Alto, United States Operational
AnHeart TherapeuticsPrecision medicine biopharmaceutical company leveraging expertise in clinical research and development and product registration focusing initially on oncology products Huangpu, China Acquired
Contraria BiotechDevelops innovative, cost-effective therapeutic and prophylactic drugs to combat global health challenges like antibiotic resistance, emerging diseases, and pandemics Siena, Italy Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Oak Investment
  • Salix Ventures
  • BBH Capital Partners

Other known investors1 additional known investor

  • Universal Health Services
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Psychiatric Solutions on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Psychiatric Solutions’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.